US Stock MarketDetailed Quotes

ALNY Alnylam Pharmaceuticals

Watchlist
  • 295.930
  • -0.820-0.28%
Close Oct 18 16:00 ET
  • 295.930
  • 0.0000.00%
Post 20:02 ET
37.99BMarket Cap-528446P/E (TTM)

Alnylam Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Alnylam Pharmaceuticals Q3 2024 Estimates Date

Currency：USDOct 31, 2024

Estimate YoY
Revenue
526.42M
-29.86%
EPS
-0.96
-181.14%
Analyst Rating
Buy

Oct 20, 2024

Alnylam Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 22 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 549.152M--
Oct 31, 20242024/Q3-- / 526.419M--
Aug 1, 20242024/Q2659.825M / 444.155M--
May 2, 20242024/Q1494.333M / 426.730M--
Feb 15, 20242023/Q4439.718M / 442.296M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 549.152M--
Oct 31, 20242024/Q3-- / 526.419M--
Aug 1, 20242024/Q2659.825M / 444.155M--
May 2, 20242024/Q1494.333M / 426.730M--
Feb 15, 20242023/Q4439.718M / 442.296M--

Unlock Free Earnings Estimates

Alnylam Pharmaceuticals Earnings Reports

  • Alnylam Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 1 08:26 ET

  • Alnylam Pharmaceuticals | 10-Q: Q1 2024 Earnings Report

    May 2 08:23 ET

  • Alnylam Pharmaceuticals | 10-K: FY2023 Annual Report

    Feb 15 16:29 ET

  • Alnylam Pharmaceuticals | 10-Q: Q3 2023 Earnings Report

    Nov 2, 2023 08:22 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 20, 2024

    Buy

    • Buy

      72.73%

    • Hold

      27.27%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data